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ABSTRACT 
Optimization of the process of biotransformation of hydroquinone into its β-D-glucoside – arbutin, was per-
formed in agitated shoot cultures of Schisandra chinensis. The optimisation involved testing various con-
centrations of the precursor and different ways of administering it. Arbutin was accumulated mainly in the 
in vitro cultured biomass (85.2–98.6%). By optimizing the process, a 2.26-fold increase in the overall prod-
uct content was obtained. The highest amount (17.8 mg·g–1 DW) was found after administering 384 mg·l–1 
hydroquinone in a dose divided into two portions. An experiment with the biotransformation of 4-hydro- 
xybenzoic acid did not produce arbutin but a mixture of two products of glucosylation of the precursor – 
hydroxybenzoic acid 4-O-β-glucopyranoside and 4-hydroxybenzoic acid β-glucopyranosyl ester. The iden-
tity of all biotransformation products was confirmed by 1H-NMR analysis. The results for the production of 
arbutin by the biotransformation of hydroquinone are of potential practical importance. On the other hand, 
the fact of confirming the presence of two glucosylation products has a great cognitive value. 
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INTRODUCTION 
Arbutin (β-D-glucoside of hydroquinone) is 
a known plant metabolite important in pharmacy and 
cosmetology. Disinfecting properties of this com-
pound are used in phytotherapy, especially in the 
treatment of urinary tract inflammation [Stammwitz 
1998, WHO… 2002, Quintus et al. 2005, Wichtl 
2007]. The cosmetics industry, on the other hand, 
makes use of the skin-lightening effect of arbutin 
because arbutin inhibits melanin formation due to its 
tyrosinase inhibitory activity [Akiu et al. 1988]. The 
new directions of the biological activity of arbutin 
proven in recent times, its antioxidant, anti-
inflammatory, antifungal and antitumour properties, 
greatly extend the range of possible applications of 
this compound [Azadbakht et al. 2004]. Recently, 
Migas and Krauze-Baranowska [2015] summarized 
the latest findings and significance of arbutin and its 
derivatives in therapy and cosmetics.  
Arbutin is present in selected plant taxa, mainly in 
the species of the families Ericaceae, Saxifragaceae, 
and Rosaceae [WHO… 2002, Wichtl 2007]. The 
classic pharmacopoeial material, authorized for use 
for medicinal purposes in the European Union coun-
tries, are the leaves of the bearberry plant (Uvae ursi 
 a.szopa@uj.edu.pl  
© Copyright by Wydawnictwo Uniwersytetu Przyrodniczego w Lublinie             
 
Szopa, A., Kwiecień, I., Ekiert, H. (2017). Biotransformation of hydroquinone and 4-hydroxybenzoic acid in Schisandra chinensis 
(Chinese magnolia vine) in vitro cultures. Acta Sci. Pol. Hortorum Cultus, 16(6), 57–66. DOI: 10.24326/asphc.2017.6.5 
 
 
 
  
www.hortorumcultus.actapol.net 58 
folium) [European Pharmacopoeia 2016b]. In Asia, 
a rich source of this compound are species of the 
genera Bergenia and Pyrus [Ekiert et al. 2012].  
Acquisition of the European material mentioned 
above is difficult due to, among other things, the 
protection of this species in Central European coun-
tries and special habitat requirements of this dwarf 
forest shrub (adequate soil acidity and the presence 
of mycorrhizal fungi) [Pękoś-Mirkowa et al. 2003,  
Recasens et al. 2008]. Some solution has been pro-
vided by the successful attempts at cultivation in 
Europe of the arbutin-rich Asian species Bergenia 
cordifolia. Another possibility is chemical synthesis 
of arbutin. However, it is a complex, three-step 
process. That is why other alternative sources of 
arbutin, including biotechnological solutions, are 
still being awaited [Ekiert et al. 2012]. Taking ad-
vantage of the enzymatic potential of microorgan-
isms, it is possible to obtain α-arbutin, an isomer of 
the plant metabolite β-arbutin [Kurosu et al. 2002]. 
More relevant work in this field of plant biotechnol-
ogy is thus being undertaken. The most promising 
solution is the possibility of obtaining β-arbutin by 
biotransformation of simple phenolic compounds in 
plant cultures in vitro (fig. 1) [Ekiert et al. 2012]. 
In these processes, advantage is taken of the enzy-
matic potential of plant cells.  
Hydroquinone – the precursor of arbutin is 
formed as a result of oxidative decarboxylation of  
4-hydroxybenzoic acid. In plants, this acid can be 
synthesized from both phenylalanine and tyrosine in 
the presence of phenylalanine ammonia lyase (PAL) 
or tyrosine ammonia lyase (TAL) [Mandal et al. 
2010]. The best-known biosynthetic pathway leads 
via cinnamic acid and p-coumaric acid, and its active 
form p-coumaroyl-CoA (fig. 1).  
A good exogenous substrate most often used for 
the reaction that leads to the formation of arbutin is 
hydroquinone. This is because of the prevalence in 
plants of enzymes from the group of β-glucosyl trans-
ferases and the lack of substrate specificity shown by 
them. The β-D-glucosylation reaction can therefore 
occur in in vitro cultures of many plant species that 
under natural conditions do not produce arbutin 
[Skrzypczak-Pietraszek et al. 2005, Piekoszewska et 
al. 2010]. 
Schisandra chinensis (Turczaninow) Baillon 
(Schizandra chinensis, Chinese magnolia vine), Schi-
sandraceae, is a Far-Eastern species native to China, 
Korea, Japan and Russia, with medicinal, cosmetic, 
and culinary qualities [Hancke et al. 1999, Panossian 
and Wikman 2008, Szopa and Ekiert 2014, Szopa et 
al. 2017a]. Schisandrae chinensis fructus has been 
listed in European pharmacopoeial documents since 
2008 as an important material that exhibits hepato-
protective, antioxidant, anticancer, and adaptogenic 
activities, among others [European Pharmacopoeia 
2008, 2016a]. The fruit is also recognized by the 
official medicine in Japan, Korea, China and Russia 
[Szopa and Ekiert 2014, Szopa et al. 2016a], as well 
as in the USA [United States Pharmacopoeia 1999]. 
Since 2007, it has been listed in Pharmacopoeia In-
ternationalis published by WHO… [2007]. The main 
group of compounds characteristic of this plant spe-
cies, especially in the fruits, are dibenzocyclooctadi-
ene lignans. The material also contains terpene com-
pounds and anthocyanin glycosides. Additionally, the 
presence of various glycosidic conjugates, including 
flavonoids, has been confirmed in the leaves [Szopa 
et al. 2017a]. Recently, the value of S. chinensis has 
also been recognized in cosmetology [Szopa et al. 
2016b]. 
The in vitro cultures of S. chinensis established in 
our laboratory, with different degrees of differentia-
tion, maintained as both solid and agitated cultures, 
had shown the capacity for the production of lignans 
and phenolic acids [Szopa and Ekiert 2014, Szopa et 
al. 2016a, 2017a, 2017b]. Those results and the con-
firmed presence of glycoside conjugates in the parent 
plant had encouraged us to investigate the efficiency 
of β-D-glucosylation of hydroquinone to arbutin.  
Our preliminary studies had shown that the cells 
in the agitated shoot cultures did convert exogenous 
hydroquinone into arbutin and that a good production 
medium was the Murashige and Skoog (MS) [1962] 
medium with 3 mg·l–1 BA and 1 mg·l–1 NAA. This 
medium was selected for further studies.  
The aim of the current work was optimization of 
the conversion process, which consisted in testing 
different doses of the precursor (96–384 mg·l–1) and 
different methods of administering it (a single dose, 
or divided into 2 or 3 portions). 
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Fig. 1. Possible ways of arbutin biogenesis 
Source: acc. Ekiert et al. [2012] 
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In in vitro cultures of selected plant species, 
a good arbutin substrate, often better than hydro-
quinone, is 4-hydroxybenzoic acid (fig. 1) [Dušková 
et al. 1999]. An additional objective of our study was 
therefore to assess the possibility of converting 
4-hydroxybenzoic acid into arbutin by S. chinensis 
cells cultured in vitro. The products of this biotrans-
formation could be of interest from a cognitive and 
practical point of view. 
MATERIALS AND METHODS 
Initial in vitro cultures 
Cultures of Schisandra chinensis were initiated 
from leaf buds of the plants growing in Rogów Arbo-
retum, Warsaw University of Life Sciences, Forest 
Experimental Station in Rogów (Poland) [Szopa et al. 
2016a]. The resulting shoot cultures were grown on 
the MS medium (1962) supplemented with cytokinin 
– 3 mg·l–1 BA (6-benzylaminopurine), and auxin – 1 
mg·l–1 NAA (α-naphthaleneacetic acid) (pH 5.7). The 
cultures were maintained under constant artificial 
light conditions (16 µmol·m–2·s–1, LF-40 W lamp, 
daylight, Piła), at 25 ±2°C.  
Experimental agitated shoot cultures 
For agitated shoot cultures, 500 ml Erlenmeyer 
flasks were filled with 100 ml of the MS medium 
[1962] supplemented with BA (3 mg·l–1) and NAA 
(1 mg·l–1) (pH 5.7). The inoculum for the cultures 
was 4 g of fresh biomass per flask. The cultures were 
maintained under the same light and temperature 
conditions as the initial cultures. The flasks were 
mounted on an Altel rotary shaker operating at 
140 rpm with a vibration amplitude of 35 mm. 
Biotransformation of hydroquinone 
Hydroquinone (Merck, Darmstadt, Germany) 
was introduced as an aqueous solution (1 or 
2 mg·ml–1) 14 days after inoculation. It was admin-
istered into the culture flasks aseptically through 
a 0.22 µm membrane filter (Merck-Millipore, 
Darmstadt, Germany). Fresh medium (100 ml) of 
was also added to each flask. The final concentra-
tions of hydroquinone were: 96, 144, 192, 288, and 
384 mg·l–1 of medium. Hydroquinone was adminis-
tered in a single dose or in split doses as two or 
three portions added at 24 h intervals. Harvesting of 
the biomass and culture media was carried out 
separately 24 h after the last dose of the precursor. 
The biomass was dried and the media lyophilized. 
The experimental combinations were run independ-
ently in three replications. 
Biotransformation of 4-hydroxybenzoic acid 
The reaction substrate, 4-hydroxybenzoic acid 
(Sigma-Aldrich, St. Louis, USA), was introduced as 
an aqueous solution (1 mg·ml–1) 14 days after inocu-
lation. It was administered into the culture flasks 
aseptically through a 0.22 µm membrane filter 
(Merck-Millipore, Darmstadt, Germany). Fresh me-
dium (100 ml) was also added to each flask. The 
final  concentration of 4-hydroxybenzoic acid was 
200 mg·l–1 of medium. The acid was administered in 
a single dose. Harvesting of the biomass and culture 
media was carried out separately 3, 6, 9, 24, 72, 
96 and 120 h after the addition of the precursor. 
The biomass was dried and the media lyophilized. 
Extraction and chromatographic analysis 
Dried biomass (1 g) was ground and subjected to 
extraction twice with boiling methanol (2 × 50 ml) 
for 4 h (2 × 2 h). The methanol was evaporated and 
the residue was dissolved in HPLC grade methanol. 
The lyophilized media were also dissolved in me- 
thanol. 
The methanolic extracts were analyzed by HPLC 
[Štambergová et al. 1985]. An HPLC-system (Hi-
tachi, Tokyo, Japan) and Purospher RP-18e analytical 
column (4 × 250 mm, 5 µm) (Merck, Darmstadt, 
Germany) with the mobile phase consisting of 
methanol/water (1 : 9, v/v) were used for separation 
at a flow rate of 1 ml·min–1. Arbutin and hydro-
quinone were detected at 285 nm using a diode array 
detector (retention times: 3.7 and 5.5 min, respec-
tively). Qualification and quantification were based 
on comparisons with reference standards. The 
amounts of the compounds were calculated from 
calibration curves by comparing the mean peak areas 
with those for standard concentrations.  
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Biotransformation efficiency 
The following formula was used to calculate the 
efficiency of the biotransformation of hydroquinone 
into arbutin: efficiency = a/b × 100% (a – overall 
amount of arbutin produced per Erlenmeyer flask (in 
the biomass and in 250 ml of medium); b – maximum 
amount of arbutin that can theoretically be obtained 
from a given amount of hydroquinone (calculated 
from the molar masses of the compounds)). 
Isolation and identification of arbutin 
Methanolic extract (384 mg·l–1, 2 portions of pre-
cursor) was chromatographed on TLC plates (Merck, 
Darmstadt, Germany, No. 1.05553.0001) with ethyl 
acetate : formic acid : water (88 : 6 : 6, v/v/v) solvent 
system. Fractions containing arbutin were eluted with 
methanol and analyzed by TLC with n-hexane : ethyl 
acetate : methanol (2 : 1 : 2, v/v/v) as eluent. 1H-NMR 
spectrum was prepared (AVANCE III Bruker, Et-
tlingen, Germany, 500 MHz, CD3OD). 
Isolation and identification of 4-hydroxybenzoic 
acid biotransformation products 
Methanolic extract (72 h after addition of the pre-
cursor at 200 mg·l–1) was chromatographed on 
TLC   plates (Merck, Darmstadt, Germany, No. 
1.05553.0001) with ethyl acetate : methanol : water 
(100 : 17 : 13, v/v/v) solvent system. Fractions con-
taining the biotransformation product were eluted 
with methanol and analyzed by TLC with n-hexane : 
ethyl acetate : methanol (2 : 1 : 2, v/v/v) as eluent. 
1H-NMR spectrum was prepared (AVANCE III 
Bruker, Ettlingen, Germany, 500 MHz, CD3OD). 
Statistical analysis 
Results are presented as the mean ± SD of three 
independent determinations. Statistical significance 
of the differences was assessed using a two-way 
ANOVA followed by the Least Significant Differ-
ence Test for post-hoc comparisons. The differ-
ences were statistically significant when p < 0.05. 
The analyses were performed using Statistica ver. 10. 
RESULTS 
Biotransformation of hydroquinone 
Identification of the product – arbutin. Biotrans-
formation of exogenous hydroquinone in Schisandra 
chinensis cultures in vitro resulted in the formation of 
arbutin. The identity of the compound, which was 
isolated from methanolic extracts from the biomass 
from in vitro cultures, was confirmed by compar-
ing  the chromatographic parameters (Rf-TLC, Rt-
HPLC), and UV-Vis and 1H-NMR spectra with those 
of the standard substance – arbutin (Sigma-Aldrich, 
St. Louis, USA). The same resonance signals were 
present in the 1H-NMR spectrum of the test sample 
and that of the arbutin standard [Kwiecień et al. 2013, 
Chen et al. 2014]. 
Optimization of the biotransformation  
of hydroquinone 
In order to optimize the process of biotransfor-
mation of hydroquinone, the precursor was adminis-
tered in different doses, in the range 96–384 mg·l–1. 
According to the literature data and results of our 
own studies, higher doses of hydroquinone (above 
100 mg·l–1) have an adverse effect on both the mor-
phological appearance of the in vitro cultured bio-
mass and its growth and biosynthetic capacity [Yo-
koyama and Inomata 1998]. In the present experi-
ment, there were no adverse effects of single high 
doses of hydroquinone (192–384 mg·l–1) on biomass 
growth (0.5–0.52 g DW). Only in the case of the 
highest dose of the precursor administered in por-
tions did we observe slight inhibition in the growth 
of biomass (0.43 g DW). The increase in biomass in 
agitated cultures of S. chinensis resulting from addi-
tion of precursors has been included in the graph in 
Figure 2.  
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Fig. 2. The growth curve of fresh (A) and dry biomass (B) in agitated cultures of S. chinensis 
Source: own research 
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Fig. 3. 4-Hydroxybenzoic acid biotransformation products 
Source: based on own research 
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Table 1. Amounts of arbutin and the efficiency of the biotransformation process in in vitro shoot cultures of Schisandra 
chinensis grown on MS medium (BA – 3 mg·l-1 and NAA – 1 mg·l-1). Statistically significant differences p < 0.05 (n = 3) 
Concentration 
of precursor 
(mg·l-1) 
Method 
of precursor 
supply 
Arbutin 
in biomass 
(mg·flask-1) 
Arbutin 
in medium 
(mg·flask-1) 
Total arbutin  
content  
(mg·flask-1) 
Biotransformation  
efficiency 
(%) ± SD 
a) single dose 8.6 0.12 8.7 ±2.15 e f h k l m n o 14.7 ±3.62 c d g h i j k l m n o 
b) 2 portions 9.6 0.74 10.3 ±1.04 k l n o 17.4 ±1.75 d g h i j k l m n o  96 
c) 3 portions 11.5 0.37 11.9 ±1.80 k n 20.0 ±3.04 a d e f g h i j k l m n o 
d) single dose 9.0 0.29 9.3 ±1.76 e f h k l m n o 10.4 ±1.97 a b c e f j m o 
e) 2 portions 13.1 0.27 13.3 ±1.87 a d n 15.0 ±2.10 c d g h i j k l m n o  144 
f) 3 portions 12.4 0.87 13.2 ±1.58 a d k n 14.9 ±1.77 c d g h i j k l m n o 
g) single dose 11.5 0.14 11.7 ±0.43 k n o 9.8 ±0.36 a b c e f j m o 
h) 2 portions 11.0 0.30 11.3 ±0.34 a d k n 9.5 ±0.29 a b c e f m o 192 
i) 3 portions 10.0 0.58 10.6 ±1.54 k n o 8.9 ±1.29 a b c e f 
j) single dose 10.6 0.65 11.2 ±1.04 k n o 6.3 ±0.58 a b c d e f g 
k) 2 portions 16.4 0.30 16.7 ±4.92 a b c d f g h i j 9.4 ±2.76 a b c e f 288 
l) 3 portions 12.9 0.99 13.9 ±4.94 a b d n 7.8 ±2.78 a b c e f 
m) single dose 13.4 0.70 14.1 ±2.24 a d n 6.0 ±0.94 a b c d e f g h  
n) 2 portions 16.3 1.59 17.8 ±5.91 a b c d e f g h i j l m 7.5 ±2.49 a b c e f 384 
o) 3 portions 12.0 2.09 14.1 ±5.65 a b d g i j 5.9 ±2.38 a b c d e f g h 
Source: own research 
 
 
Arbutin was accumulated mainly in the in vitro 
grown biomass. At hydroquinone doses in the range 
96–288 mg·l–1, the amount of the product in the bio-
mass was from 8.6 to 16.4 mg per flask–1, and in the 
media it ranged from 0.12 to 0.87 mg·flask–1 (tab. 1). 
At the highest hydroquinone dose tested (384 mg·l–1), 
the concentration of arbutin was higher and varied 
between 12.0 and 16.3 mg·flask–1, depending on the 
method of administering the precursor. The overall 
arbutin content (in the biomass and culture medium) 
varied over a wide range, depending on the concen-
tration of the precursor, from 8.7 to 17.8 mg·flask–1 
(tab. 1). 
The arbutin content ranged from 8.6 to 
16.4 mg·flask–1 in the biomass, and from 0.12 to 
2.09 mg·flask–1 in the culture media (tab. 1).  
When the concentration of exogenous hydro-
quinone administered in single, undivided doses in-
creased from 96 to 384 mg·l–1, the arbutin content in 
the biomass increased from 8.6 to 13.4 mg·flask–1 in 
the biomass, and from 0.12 to 0.70 mg·flask–1 in the 
media. When hydroquinone was administered in split 
doses, the overall arbutin content (in the biomass and 
medium) increased by as much as 7.5 mg (from 10.3 
to 17.8 mg·flask–1, 2 portions), and by 3.5 mg (from 
10.6 to 14.1 mg·flask–1, 3 portions) (tab. 1). Adminis-
tering hydroquinone in doses divided into two por-
tions caused the amount of the product to increase 
from 9.6 to 16.4 mg·flask–1 in the biomass, and from 
0.27 to 1.59 mg·flask–1 in the media. When hydro-
quinone was administered in 3 portions, the arbutin 
content in the biomass increased to a lesser extent, 
from 10.0 to 12.9 mg·flask–1, but the amount of the 
product in the media increased markedly, from 0.37 
to 2.09 mg·flask–1 (tab. 1). Statistically significant 
differences (p < 0.05) in arbutin content were found 
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between hydroquinone concentration and hydro-
quinone supply. 
The efficiency of the process of biotransforma-
tion of hydroquinone into arbutin was low, ranging 
from 5.9 to 20.0%, depending on the concentration 
of the precursor and the method of administering it 
(tab. 1). The highest efficiencies of 17.4% and 
20.0% were obtained after applying the lowest dose 
of hydroquinone (96 mg·l–1) in 2 and 3 portions, 
respectively (tab. 1). With the increase in the con-
centration of a single hydroquinone dose (from 96 
to 384 mg·l–1), the efficiency of the process de-
creased markedly from 14.7 to 6.0%. When increas-
ingly higher doses of the precursor were adminis-
tered in 2 or 3 portions, there was also a marked 
decrease in the efficiency of the process, from 17.4 
to 7.5% (2 portions) and from 20.0 to 5.9% (3 por-
tions) (tab. 1). In terms of reaction efficiency, sta-
tistically significant differences (p < 0.05) between 
hydroquinone concentration and hydroquinone 
supply were found. 
Biotransformation of 4-hydroxybenzoic acid 
Identification of the products. Following the bio-
transformation of exogenous 4-hydroxybenzoic acid 
in Schisandra chinensis cultures in vitro, the presence 
of arbutin was not confirmed. The cells did convert 
the supplied substrate into one main product, but with 
chromatographic parameters different from those of 
arbutin (Rf = 0.73, Rt = 11.05 min). That product was 
isolated and purified. Then its identity was deter-
mined by 1H-NMR spectral analysis. The prod-
uct was found to be a mixture of two compo- 
unds, products of glucosylation of 4-hydroxybenzoic 
acid: 4-hydroxybenzoic acid 4-O-β-glucopyranoside 
and 4-hydroxybenzoic acid β-glucopyranosyl ester  
(1 : 0.56) (fig. 3) [Klick and Herrmann 1988, Keller 
et al. 1996]. 
DISCUSSION 
In our study on the optimization of the bioconver-
sion of hydroquinone into arbutin we did not observe 
what is often described in the literature as a very 
unfavourable, damaging effect of higher doses of that 
precursor (above 100 mg·l–1) on the cells cultured in 
vitro [Yokoyama and Inomata 1998]. Only at the 
highest dose of the precursor (384 mg·l–1) did we 
observe inhibition in the growth of the biomass of 
Schisandra chinensis shoots. The high degree of 
organogenesis of the in vitro grown biomass used in 
the experiment (shoot cultures) guaranteed that it 
was less sensitive to the damaging effect of hydro-
quinone. Likewise, in in vitro cultures of other plant 
species with a high degree of differentiation, carried 
out in our laboratory, such as shoot cultures of Ruta 
graveolens, Hypericum perforatum and Aronia 
melanocarpa, and shoot-differentiating callus cul-
tures of Ruta graveolens ssp. divaricata, there had 
been no evidence of the damaging effect of hydro-
quinone on the biomass [Dušková et al. 1999, Zubek 
et al. 2009, Piekoszewska et al. 2010, Kwiecień et 
al. 2013]. 
As a result of the optimization of the biotransfor-
mation process, we obtained a 2.26-fold increase in 
the arbutin content in the cultured biomass. Similar 
increases in the arbutin content in the biomass had 
also been obtained by us in the studies with in vitro 
cultures of Ruta graveolens ssp. divaricata and Aro-
nia melanocarpa (2.6- and 2.4-fold, respectively) 
[Zubek et al. 2009, Kwiecień et al. 2013]. 
The highest overall arbutin content (total content 
in the biomass and medium) obtained by us was 
3.90 g·100 g–1DW. In a study conducted by Dušková 
et al. [1999], the arbutin content was higher – 
5.01 g·100 g–1DW. Our determinations of arbutin 
content were made in samples collected 24 hours 
after the last dose of the precursor. The results ob-
tained by Dušková et al. [1994] were measurements 
after 7 days (168 hours). It can thus be assumed that 
by continuing the optimization of the process we 
could have obtained even larger amounts of the prod-
uct. Other studies on the biotransformation of hydro-
quinone into arbutin had indicated that the dynamics 
of β-D-glucosylation in in vitro cultures of different 
plant species were different. The maximum amounts 
of the product had been obtained by us at different 
times after administering the precursor: 18 h (Ruta 
graveolens, Melittis melissophyllum), 24 h (Echina-
cea purpurea), 48 h (Exacum affine), and 72 h (Ruta 
graveolens ssp. divaricata) [Skrzypczak-Pietraszek et 
al. 2005]. 
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The maximum efficiency of the process of bio-
transformation of hydroquinone into arbutin obtained 
by us in the present study (approx. 20%) was low, 
lower than what we had obtained with in vitro cul-
tures of other plant species – Ruta graveolens, Hy-
pericum perforatum and Aronia melanocarpa [Duš-
ková et al. 1999, Piekoszewska et al. 2010]. 
In in vitro cultures of some plant species, another 
arbutin precursor that is as good as, or better than, 
hydroquinone is 4-hydroxybenzoic acid. This has 
been demonstrated for cultures of Bellis perennis, 
Bergenia crassifolia, and Leuzea carthamoides, 
among others [Štambergová et al. 1985].  
In our experiment with 4-hydroxybenzoic acid, 
we found that in S. chinensis in vitro cultures this 
compound was not converted into arbutin. Two com-
pounds were formed as biotransformation products – 
hydroxybenzoic acid 4-O-β-glucopyranoside and  
4-hydroxybenzoic acid β-glucopyranosyl ester in 
a ratio of 1 : 0.56 [Klick and Herrmann 1988, Keller 
et al. 1996]. The fact of confirming the presence of 
hydroxybenzoic acid 4-O-β-glucopyranoside and  
4-hydroxybenzoic acid β-glucopyranosyl ester in 
S. chinensis cultures is extremely important from 
a cognitive point of view. It is an indication of a con-
siderable enzymatic potential of those cultures. At the 
same time, it is yet another proof of how easily the  
β-glucosylation reaction proceeds in plant cultures 
in vitro. 
CONCLUSIONS 
Although the metabolism of the cells from our in 
vitro cultures of Schisandra chinensis with a high 
degree of organogenesis is mainly directed towards 
the production of lignans, as evidenced by the results 
of our research [Szopa and Ekiert 2014, Szopa et al. 
2016a, 2017b, 2017c], the current study has demon-
strated other biosynthetic capabilities of cells from 
these cultures, leading to the formation of arbutin – 
an important product in phytotherapy and cosmetol-
ogy. Moreover, the fact of confirming the presence of 
two glucosylation products as the result of bioconver-
sion of 4-hydroxybenzoic acid is of significant cogni-
tive importance. 
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